Description

Interdose symptoms are breakthrough symptoms for a person being treated with an antidepressant or antianxiety agent.


 

Features:

(1) The patient is regularly taking the medication in maintenance doses.

(2) Prior to the next dose the patient experiences symptoms of the underlying condition (anxiety, depression, other).

(3) The symptoms regress following absorption of the next dose.

 

Possible mechanism:

(1) development of tolerance to the drug dose

(2) drug interaction or comorbid condition resulting in enhanced metabolism or excretion

(3) interval between doses is greater than the duration of clinical action

(4) onset of withdrawal symptoms

(5) worsening of the underlying condition

 

Possible solutions:

(1) increase the drug dose

(2) increase dosing frequency

(3) identify and modify the interacting condition

(4) switch to an extended release formulation

 

Differential diagnosis:

(1) drug discontinuation syndrome

(2) noncompliance (missed dose)

 


To read more or access our algorithms and calculators, please log in or register.